Ilana Tal
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 6
-
- SARS-CoV-2 and COVID-19 Research 2
- SARS-CoV-2 detection and testing 1
- Co-authors
- Gili Regev‐Yochay (9 shared papers)Nathan Keller (5 shared papers)Michal Mandelboim (2 shared papers)Sharon Amit (4 shared papers)Carmit Rubin (2 shared papers)E G Levin (2 shared papers)Yitshak Kreiss (2 shared papers)Carmit Cohen (2 shared papers)
- Journals
- Infection Control and Hospital Epidemiology (4 papers)Clinical Microbiology and Infection (2 papers)Journal of Clinical Microbiology (2 papers)The Pediatric Infectious Disease Journal (1 paper)Epidemiology and Infection (1 paper)
- Partner nations
- IsraelUnited StatesUnited Kingdom
In The Last Decade
Ilana Tal
15 papers receiving 1.5k citations
Ilana Tal's Hit Papers
Peers
Comparison fields: 5 of 95
- Molecular Medicine 487
- Applied Microbiology and Biotechnology 116
- Infectious Diseases 737
- Modeling and Simulation 111
- Endocrinology 124
Countries citing papers authored by Ilana Tal
This map shows the geographic impact of Ilana Tal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilana Tal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilana Tal more than expected).
Fields of papers citing papers by Ilana Tal
This network shows the impact of papers produced by Ilana Tal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilana Tal. The network helps show where Ilana Tal may publish in the future.
Co-authors
The 25 scholars most cited alongside Ilana Tal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Covid-19 Breakthrough Infections in Vaccinated Health Care Workers Hit paper breakdown → | 2021 | 828 |
| 2 | 2011 | 279 | |
| 3 | 2010 | 141 | |
| 4 | 2008 | 102 | |
| 5 | 2018 | 45 | |
| 6 | 2004 | 33 | |
| 7 | 2011 | 27 | |
| 8 | 2019 | 24 | |
| 9 | 1988 | 23 | |
| 10 | 2017 | 16 | |
| 11 | 2023 | 14 | |
| 12 | 2021 | 12 | |
| 13 | 2022 | 4 | |
| 14 | 2021 | 3 | |
| 15 | 2023 | 1 | |
| 16 | 2015 | 0 |
About Ilana Tal
Ilana Tal is a scholar working on Molecular Medicine, Infectious Diseases, Clinical Biochemistry, Pharmacology and Biological Psychiatry, having authored 16 papers that have together received 1.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Infection Control and Ventilation (1 paper), Psychology of Social Influence (1 paper), Antibiotic Use and Resistance (1 paper), SARS-CoV-2 detection and testing (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Molecular Medicine (487 citations), Applied Microbiology and Biotechnology (116 citations), Infectious Diseases (737 citations), Modeling and Simulation (111 citations) and Endocrinology (124 citations). Ilana Tal has collaborated with scholars based in Israel, United States and United Kingdom. Frequent co-authors include Gili Regev‐Yochay, Nathan Keller, Michal Mandelboim, Sharon Amit, Carmit Rubin, E G Levin, Yitshak Kreiss, Carmit Cohen, Victoria Indenbaum and Yaniv Lustig. Their work appears in journals such as Infection Control and Hospital Epidemiology, Clinical Microbiology and Infection, Journal of Clinical Microbiology, The Pediatric Infectious Disease Journal and Epidemiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.